Red X iconGreen tick iconYellow tick icon

Christopher FramptonProfessor

BSc(Hons) PhD(Cant)

Chris Frampton is the departmental biostatistician and is involved in departmental teaching and the design and analysis of research studies.

His particular research interests include the modelling and prediction of long-term outcome data, and developing structural equation models for defining personality constructs.

Publications

Weinkove, R., George, P., Fyfe, R., Dasyam, N., Nouri, Y., Ostapowicz, T., … Frampton, C. M. A., … Hermans, I. (2023). A phase 1 dose escalation trial of third-generation CD19-directed CAR T-cells incorporating CD28 and toll-like receptor 2 (TLR2) intracellular domains for relapsed or refractory B-cell non-Hodgkin lymphomas (ENABLE). Blood, 142(Suppl. 1), (pp. 890-892). doi: 10.1182/blood-2023-178872

Donovan, K. A., Beaglehole, B., Frampton, C. M. A., Currie, M., Boden, J. M., & Jordan, J. (2023). Tōku Oranga: The subjective wellbeing and psychological functioning of postgraduate and medical students in Ōtautahi Christchurch. New Zealand Medical Journal/Te ara tika o te hauora hapori, 136(1586), 51-62. Retrieved from https://journal.nzma.org.nz/

Lingard, M. C. H., Teo, Y., Frampton, C. M. A., & Hooper, G. J. (2023). Effect of surgeon-specific feedback on surgical outcomes: A systematic review of the literature. ANZ Journal of Surgery. Advance online publication. doi: 10.1111/ans.18772

Prendergast, E., Dalbeth, N., Bursill, D., Frampton, C., & Stamp, L. (2023). Adherence to the Gout and Crystal Arthritis Network (G-CAN) consensus statements for gout nomenclature. Arthritis & Rheumatology, 75(Suppl. 9), 0238. doi: 10.1002/art.42700

Tennant, M., Frampton, C., Mulder, R., & Beaglehole, B. (2023). Polypharmacy in the treatment of people diagnosed with borderline personality disorder: Repeated cross-sectional study using New Zealand's national databases. BJPsych Open, 9(6), e200. doi: 10.1192/bjo.2023.592

Back to top